Hangzhou Tianmushan Pharmaceutical Enterprise Co LtdSSE: 600671

Report for Q1 2025

Apr 28, 2025 · Issued by Hangzhou Tianmushan Pharmaceutical Enterprise Co Ltd via Shanghai Stock Exchange

Filed with SSE · Apr 28, 2025

On 6ix: 6ix.com/news/report-for-q1-2025-214

Report for Q1 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Hangzhou Tianmushan Pharmaceutical Enterprise Co Ltd on 6ix

Earlier from Hangzhou Tianmushan Pharmaceutical Enterprise

Announcement on Progress in Application for the Removal of Other Risk Warnings for Corporate StocksApr 23, 2025
Announcement on Resolution of the 2024 Annual General MeetingApr 22, 2025
Announcement on Resolutions of the 12th Meeting of the 12th Board of DirectorsApr 11, 2025
Announcement on Not Profit Distribution for 2024Apr 1, 2025
Announcement on Resolution of the 1st Extraordinary General Meeting in 2025Mar 27, 2025

Later from Hangzhou Tianmushan Pharmaceutical Enterprise

Announcement on Resolution of the 2nd Extraordinary General Meeting in 2025Apr 29, 2025
Announcement on Reply to Letter from Shanghai Stock Exchange on Information SupervisionMay 17, 2025
Announcement on Convening the 2024 Annual Performance BriefingMay 27, 2025
Announcement on Outline of the 2024 Annual Performance BriefingJun 6, 2025
Announcement on Expected Increase in Semi-annual Performance for 2025Jul 15, 2025

All Hangzhou Tianmushan Pharmaceutical Enterprise news releases

Follow Hangzhou Tianmushan Pharmaceutical Enterprise into a list and get an email when it puts out news.

Follow Hangzhou Tianmushan Pharmaceutical Enterprise